...
首页> 外文期刊>Biotechnology Progress >Efficient Expansion of Mesenchymal Stromal Cells in a Disposable Fixed Bed Culture System
【24h】

Efficient Expansion of Mesenchymal Stromal Cells in a Disposable Fixed Bed Culture System

机译:一次性固定床培养系统中间充质基质细胞的有效扩增

获取原文
获取原文并翻译 | 示例
           

摘要

The need for efficient and reliable technologies for clinical-scale expansion of mesenchymal stromal cells (MSC) has led to the use of disposable bioreactors and culture systems. Here, we evaluate the expansion of cord blood-derived MSC in a disposable fixed bed culture system. Starting from an initial cell density of 6.0 × 10~7 cells, after 7 days of culture, it was possible to produce of 4.2(±0.8) × 10~8 cells, which represents a fold increase of 7.0 (±1.4). After enzymatic retrieval from Fibra-Cell disks, the cells were able to maintain their potential for differentiation into adipocytes and osteocytes and were positive for many markers common to MSC (CD73, CD90, and CD105). The results obtained in this study demonstrate that MSC can be efficiently expanded in the culture system. This novel approach presents several advantages over the current expansion systems, based on culture flasks or microcarrier-based spinner flasks and represents a key element for MSC cellular therapy according to GMP compliant clinical-scale production system.
机译:对用于间充质基质细胞(MSC)临床规模扩展的高效可靠技术的需求导致了一次性生物反应器和培养系统的使用。在这里,我们评估一次性固定床培养系统中脐血来源的MSC的扩增。从最初的细胞密度6.0×10〜7个细胞开始,培养7天后,有可能产生4.2(±0.8)×10〜8个细胞,这代表增加了7.0(±1.4)倍。从Fibra-Cell磁盘上酶促检索后,细胞能够维持其分化为脂肪细胞和骨细胞的潜力,并且对MSC常见的许多标记(CD73,CD90和CD105)呈阳性。在这项研究中获得的结果表明,MSC可以在培养系统中有效扩展。这种新颖的方法相对于基于培养瓶或基于微载体的旋转瓶的当前扩展系统具有多种优势,并且代表了符合GMP的临床规模生产系统进行MSC细胞治疗的关键要素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号